Immunologic Research

, Volume 12, Issue 2, pp 131–148 | Cite as

Cellular basis of T-cell autoreactivity in autoimmune diseases

  • Claude Carnaud
  • Jean-François Bach
Symposium

Abstract

There is no doubt that T cells play a key role in the pathogenesis of autoimmune diseases (AD) both as effector and regulatory cells. Despite spectacular progress in the understanding of natural tolerance to self, owing particularly to transgenic technology, important questions remain open regarding the pathogenesis of AD, the conditions favoring the transition from benign or ‘physiological’ autoimmunity to deleterious autoimmunity, and the precise effector mechanisms. This review on the cellular basis of T-cell-mediated AD begins with an enumeration of the main arguments in favor of direct T-cell involvement, special emphasis being given to two animal models which have been most extensively investigated: experimental allergic encephalomyelitis, and the nonobese diabetic mouse. The question as to whether pathogenic T cells use a restricted repertoire of Vβ genes is examined in the context of these two models. From here we proceed to an evaluation of the mechanisms of onset of AD, discussing both extrinsic and intrinsic factors responsible for the breakdown in T-cell tolerance and reviewing the arguments in favor of suppressor T cells being actively involved in the prevention of autoimmunity. The last two sections are devoted to the effector mechanisms responsible for tissue injury in organ-specific AD and to T-cell-directed therapeutic interventions, respectively. We discuss the two main pathogenic hypotheses based on direct intervention of cytotoxic T cells or indirect involvement of inflammatory cytokines and macrophages, and evaluate the importance of ecotaxis in leading autoreactive T cells to the site of injury. We conclude on a brief and nonexhaustive list of strategies aimed at selectively neutralizing potentially harmuful T cells.

Key Words

Experimental allergic encephalomyelitis Nonobese diabetic mouse Type-I diabetes Vβ repertoire Suppressor T cells Effector mechanisms of tissue injury Cytotoxic T cells Homing molecules T-cell-targetted intervention 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Miyazaki A, Hanafusa T, Yamada K, Miyagawa J, Fugino-Kuribara J, Nakagima H, Nonaka AH, Tarui S: Predominance of T lymphocytes in pancreatic islets and spleen of prediabetic nonobese diabetic (NOD) mice: A longitudinal study. Clin Exp Immunol 1985;6:622.Google Scholar
  2. 2.
    Bedossa P, Bendelac A, Bach J-F, Carnaud C: Syngeneic T cell transfer of diabetes into NOD newborn mice: In situ studies of the autoimmune steps leading to insulin-producing cell destruction. Eur J Immunol 1989;19:1947.PubMedGoogle Scholar
  3. 3.
    Fujino-Kurihara H, Fujita H, Hakura H, Nonaka K, Tarui S: Ultrastructural and immunocytochemical aspects of lymphocytic submandibulitis in the nonobese diabetic (NOD) mouse. Virchows Arch B Cell Pathol 1985;49:107.Google Scholar
  4. 4.
    Smith E, Behan WMH, Menzies CB, Behan PO: Experimental autoimmune thyroidits: Attempt to correlate disease development with lymphocyte subset changes. Clin Exp Immunol 1987;67:319.PubMedGoogle Scholar
  5. 5.
    Holoshitz J, Naparstek Y, Ben-Nun A, Cohen IR: Lines of T lymphocytes mediate or vaccinate against autoimmune arthritis. Science 1983; 219:56.PubMedGoogle Scholar
  6. 6.
    Rose NR, Kong YCM, Okayasu I, Giraldo AA, Beisel K, Sundick RS: T-cell regulation in autoimmune thyroidits. Immunol Rev 1981;55: 299.PubMedGoogle Scholar
  7. 7.
    Maron R, Zarubavel R, Friedman A, Cohen IR: T lymphocyte line specific for thyroglobulin produces or vaccinates against autoimmune thyroiditis in mice. J Immunol 1983; 131:2316.PubMedGoogle Scholar
  8. 8.
    Ben-Nun A, Wekerle A, Cohen IR: The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autcimmune encephalomyelitis. Eur J Immunol 1981;11:195.PubMedGoogle Scholar
  9. 9.
    Paterson PY, Day ED, Whitacre C: Neuroimmunologic diseases: Effector cell responses and immunoregulatory mechanisms. Immunol Rev 1981;55:89.PubMedGoogle Scholar
  10. 10.
    Like AA, Weringer EJ, Holdash Z, McGill P, Atkinson D, Rossini A: Adoptive transfer of autoimmune diabetes mellitus in biobreeding/ Wercester (BB/w) inbred and hybrid rats. J Immunol 1985;134:1583.PubMedGoogle Scholar
  11. 11.
    Wicker LS, Miller BJ, Mullen Y: Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes 1986;35:855.PubMedGoogle Scholar
  12. 12.
    Zamvil SS, Steinman L: The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol 1990;8:579.PubMedGoogle Scholar
  13. 13.
    Bendelac A, Carnaud C, Boitard C, Bach J-F: Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates: Requirement for both L3T4+ and Lyt 2+ T cells. J Exp Med 1987;166: 823.PubMedGoogle Scholar
  14. 14.
    Miller BJ, Appel MC, O'Neil JJ, Wicker LS: Both the Lyt2+ and the L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J Immunol 1988;140:52.PubMedGoogle Scholar
  15. 15.
    Reich EP, Sherwin RS, Kanagawa O, Janeway CA: An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes. Nature 1989;341:326.PubMedGoogle Scholar
  16. 16.
    Thivolet C, Bedelac A, Bedossa P, Bach J-F, Carnaud C: CD8+ T cell homing to the pancreas in the nonobese diabetic mouse is CD4+ T cell-dependent. J Immunol 1991; 146:85.PubMedGoogle Scholar
  17. 17.
    Haskins K, McDuffie M: Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. Science 1990;249:1433.PubMedGoogle Scholar
  18. 18.
    Elias D, Marcovits D, Reshef T, van der Zee R, Cohen IR: Induction and therapy of autoimmune diabetes in the nonobese diabetic (NOD/Lt) mouse by a 65 kDa heat shock protein. Proc Natl Acad Sci USA 1990; 87:1576.PubMedGoogle Scholar
  19. 19.
    Wick G, Kite JH, Witebsky E: Spontaneous thyroiditis in the obese strain of chickens. IV. The effect of thymectomy and thymo-bursectomy on the development of the disease. J Immunol 1970;101:54.Google Scholar
  20. 20.
    Ogawa M, Maruyama T, Hasegawa T, Kanaya T, Kobayashi F, Tochino Y, Uda H: The inhibitory effect of neonatal thymectomy on the incidence of insulitis in nonobese diabetic (NOD) mice. Biomed Res 1985;6:103.Google Scholar
  21. 21.
    Borel JF, Gunn HC: Cyclosporine as a new approach to therapy of autoimmune diseases. Ann NY Acad Sci 1986;475:307.PubMedGoogle Scholar
  22. 22.
    Gonatas NK, Howard JC: Inhibition of experimental allergic encephalomyelitis in rats severely depleted of T cells. Science 1974;186: 839.PubMedGoogle Scholar
  23. 23.
    Koike T, Itoh Y, Ishii T, Ito I, Takabayashi K, Maruyama N, Tomioka H, Yoshida S: Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice. Diabetes 1987;36:539.PubMedGoogle Scholar
  24. 24.
    Hayward AR, Cobbold SP, Waldmann H, Cooke A, Simpson E: Delay in onset of insulitis in NOD mice following a single injection of CD4 and CD8 antibodies. J Autoimmun 1988;1:91.PubMedGoogle Scholar
  25. 25.
    Hahn HJ, Lucke S, Kloting I, Volk HD, Baehr RV, Diamantstein T: Curing BB rats of freshly manifested diabetes by short-term treatment with a combination of a monoclonal anti-interleukin 2 receptor antibody and a subtherapeutic dose of cyclosporin A. Eur J Immunol 1987;17:1075.PubMedGoogle Scholar
  26. 26.
    Sempe P, Bedossa P, Richard MF, Villa MC, Bach J-F, Boitard C: Anti-α/β T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) mice. Eur J Immunol 1991;21:1169.Google Scholar
  27. 27.
    Kong YM, Waldmann H, Cobbold S, Giraldo AA, Fuller BE, Simon LL: Pathogenic mechanisms in murine autoimmune thyroiditis: Short-and long-term effects of in vivo depletion of CD4+ and CD8+ cells. Clin Exp Immunol 1989;77:428.PubMedGoogle Scholar
  28. 28.
    Shizuru JA, Taylor-Edwards C, Banks BA, Gregory AK, Fathman CG: Immunotherapy of the nonobese diabetic mouse: Treatment with an antibody to T-helper lymphocytes. Science 1988;240:659.PubMedGoogle Scholar
  29. 29.
    Fritz R, McFarlin DE: Encephalitogenic epitopes of myelin basic protein. Chem Immunol 1989;46:101.PubMedCrossRefGoogle Scholar
  30. 30.
    Van Eden W, Thole J, Van der Zee R, Noordzij A, Emden JDA, Hensen EJ, Cohen IR: Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature 1988;331:171.PubMedGoogle Scholar
  31. 31.
    Haskins K, Portas M, Bergman B, Lafferty K, Bradley B: Pancreatic islet-specific T-cell clones from nonobese diabetic mice. Proc Natl Acad Sci USA 1989;86:8000.PubMedGoogle Scholar
  32. 32.
    Creemers P, Rose NR, Kong CM: Experimental autoimmune thyroiditis. In vitro cytotoxic effects of T lymphocytes on thyroid monolayers. J Exp Med 1983;157:559.PubMedGoogle Scholar
  33. 33.
    Salamero J, Charreire J: Syngeneic sensitization of mouse lymphocytes as monolayers of thyroid epithelial cells. VII. Generation of thyroid specific cytotoxic effector cells. Cell Immunol 1985;91:111.PubMedGoogle Scholar
  34. 34.
    Remy JJ, Texier B, Chiocchia G, Charreire J: Characteristics of cytotoxic thyroglobulin-specific T cell hybridomas. J Immunol 1989;142: 1129.PubMedGoogle Scholar
  35. 35.
    Nagata M, Yokono K, Hayakawa M, Kawase Y, Hatamori N, Ogawa W, Yonezawa K, Shii K, Baba S: Destruction of pancreatic islet cells by cytotoxic T lymphoctes in nonobese diabetic mice. J Immunol 1989;143:1155.PubMedGoogle Scholar
  36. 36.
    Chiocchia G, Boissier MC, Ronziere MC, Herbage D, Fournier C: T cell regulation of collagen-induced arthritis in mice. I. Isolation of type II collagen-reactive T cell hybridomas with specific cytotoxic function. J Immunol 1990;145:519.PubMedGoogle Scholar
  37. 37.
    Matis LA: The molecular basis of T-cell specificity. Annu Rev Immunol 1990;8:65.PubMedGoogle Scholar
  38. 38.
    O'Reilly LA, Hutchings PR, Crocker PR, Simpson E, Lund T, Kioussis D, Takei F, Baird J, Cooke A: Characterization of pancreatic islet cell infiltrates in NOD mice: Effect of cell transfer and transgenic expression. Eur J Immunol 1991;21: 1171.PubMedGoogle Scholar
  39. 39.
    Oksenberg JR, Stuart S, Begovich AB, Bell RB, Erlich HA, Steinman L, Bernard CA: Limited heterogeneity of rearranged T-cell receptor Vα transcripts in brains of multiple sclerosis patients. Nature (Lond) 1990; 345:344.Google Scholar
  40. 40.
    Wucherpfenning KW, Ota K, Endo N, Seidman JG, Rosenzweig A, Weiner HL, Hafler DA: Shared human T cell receptor Vβ usage to immunodominant regions of myelin basic protein. Science 1990;248: 1016.Google Scholar
  41. 41.
    Martin R, Howell MD, Jaraquemada D, Flerlage M, Richert J, Brostoff S, Long EO, McFarlin DE, McFarland HF: A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. J Exp Med 1991;178: 19.Google Scholar
  42. 42.
    Ben-Nun A, Liblau RS, Cohen L, Lehmann D, Tournier-Lasserve E, Rosenzweig A, Jingwu Z, Raus JCM, Bach MA: Restricted T-cell receptor Vβ gene usage by myelin basic protein-specific T cell clones in multiple sclerosis: Predominant genes vary in individuals. Proc Natl Acad Sci USA 1991;88:2466.PubMedGoogle Scholar
  43. 43.
    Zamvil SS, Mitchell DJ, Lee NE, Moore AC, Waldor MK, Sakai K, Rothbard JB, McDevitt HO, Steinman L, Acha-Orbea H: Predominant expression of a T cell receptor Vβ gene subfamily in autoimmune encephalomyelitis. J Exp Med 1988; 167:1586.PubMedGoogle Scholar
  44. 44.
    Acha-Orbea H, Steinman L, McDevitt HO: T cell recptors in murine autoimmune diseases. Annu Rev Immunol 1989;7:371.PubMedGoogle Scholar
  45. 45.
    Kumar V, Kono DH, Urban JL, Hood L: The T cell receptor repertoire and autoimmune diseases. Annu Rev Immunol 1989;7:657.PubMedGoogle Scholar
  46. 46.
    Burns FR, Li X, Shen N, Offner H, Chou YK, Vandenbark A, Heber-Katz E: Both rat and mouse T cell receptors specific for the encephalitogenic determinants of myelin basic protein use similar Vα and Vβ chain genes. J Exp Med 1989;169: 27.PubMedGoogle Scholar
  47. 47.
    Acha-Orbea H, Mitchell DJ, Timmermann L, Wralth DC, Tausch GS, Waldor MK, Zamvil SS, McDevitt HO, Steinman L: Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 1988;54:263.PubMedGoogle Scholar
  48. 48.
    Urban JL, Kumar V, Kono DH, Gomez C, Horvath SJ, Clayton J, Ando DG, Sercarz EE, Hood L: Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 1988;54:577.PubMedGoogle Scholar
  49. 49.
    Nakano N, Kikutani H, Nishimoto H, Kishimoto T: T cell receptor V usage of islet β cell-reactive T cells is not restricted in NOD mice. J Exp Med 1991;173:1091.PubMedGoogle Scholar
  50. 50.
    Candeias S, Katz J, Benoist C, Mathis D, Haskins K: Islet-specific T-cell clones from nonobese diabetic mice express heterogeneous T-cell receptors. Proc Natl Acad Sci USA 1991;88:6167.PubMedGoogle Scholar
  51. 51.
    Bacli A, Charlton B, Mandel TE: Prevention of cyclophosphamide-induced diabetes by anti-Vβ8 T-lymphocyte receptor monoclonal antibody therapy in NOD/WEHI mice. Diabetes 1989;38:1492.Google Scholar
  52. 52.
    Livingstone A, Edwards CT, Shizuru JA, Fathman CG: Genetic analysis of diabetes in the nonobese diabetic mouse. I. MHC and T cell receptor β gene expression. J Immunol 1991;146:529.PubMedGoogle Scholar
  53. 53.
    Lipes MA, Eisenbarth GS: Transgenic mouse models of type I diabetes. Diabetes 1990;39:879.PubMedGoogle Scholar
  54. 54.
    Heber-Katz E, Acha-Orbea H: The V-region disease hypothesis: Evidence from autoimmune encephalomyelitis. Immunol Today 1989;10: 164.PubMedGoogle Scholar
  55. 55.
    Tron F, Bach J-F: Molecular and genetic characteristics of pathogenic autoantibodies. J Autoimmun 1989; 2:311.PubMedGoogle Scholar
  56. 56.
    De Carvalho LC, Tepleman J, Wick G, Roitt IM: The role of self antigen on the development of autoimmunity in obese strain chickens with spontaneous autoallergic thyroiditis. J Exp Med 1982;155:1255.Google Scholar
  57. 57.
    Waksman BH: Mechanisms in multiple sclerosis. Nature (London) 1985; 318:104.Google Scholar
  58. 58.
    Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimenta M, Cascalho M, Folli P, Richter-Olesen H, de Camilli P: Identification of the 64K autoantigen in insulin dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature (Lond) 1990;347:151.Google Scholar
  59. 59.
    Cohen IR: Autoimmunity to chaperonins in the pathogenesis of arthritis and diabetes. Annu Rev Immunol 1991;9:567.PubMedGoogle Scholar
  60. 60.
    Charreire J: Immune mechanisms in autoimmune thyroiditis. Adv Immunol 1989;46:263.PubMedCrossRefGoogle Scholar
  61. 61.
    Cohen IR, Young DB: Autoimmunity, microbial immunity and the immunologial homunculus. Immunol Today 1991;12:105.PubMedGoogle Scholar
  62. 62.
    Cox KO, Howles A: Induction and regulation of autoimmune hemolytic anemia in mice. Immunol Rev 1981;55:31.PubMedGoogle Scholar
  63. 63.
    Weigle WO: Analysis of autoimmunity through experimental models of thyroiditis and allergic encephalomyelitis. Adv Immunol 1980;30:159.PubMedGoogle Scholar
  64. 64.
    Russel AS: Drug-induced autoimmune disease. Clin Immunol Allergy 1981;1:57.Google Scholar
  65. 65.
    Bottazzo GF, Pujol-Borell R, Hanafusa T: Hypothesis: Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 1983;ii:1115.Google Scholar
  66. 66.
    Bottazzo GF, Dean BM, McNally JM, McKay EH, Swift GF, Gamble DR: In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 1985;313:353.PubMedGoogle Scholar
  67. 67.
    Sarvetnick N, Liggitt D, Pitts SL, Hansen SE, Stewart TA: Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell 1988;52:773.PubMedGoogle Scholar
  68. 68.
    Sarvetnick N, Shizuru J, Liggitt D, Martin L, McInyre B, Gregory A, Parslow T, Stewart T: Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma. Nature (Lond) 1990;346:844.Google Scholar
  69. 69.
    Bohme J, Haskins K, Stecha P, van Ewijk W, LeMeur M, Gerlinger P, Benoist C, Mathis D: Transgenic mice with I-A on islet cells are normoglycemic but immunologically intolerant. Science 1989;244:1179.PubMedGoogle Scholar
  70. 70.
    Lo D, Burkly LC, Flavell RA, Palmiter RD, Brinster RL: Tolerance in transgenic mice expressing class II major histocompatibility complex on pancreatic acinar cells. J Exp Med 1989;170:87.PubMedGoogle Scholar
  71. 71.
    Miller JFAP, Morahan G, Slattery R, Allison J: Transgenic modeis of T-cell self tolerance and autoimmunity. Immunol Rev 1990;118:21.PubMedGoogle Scholar
  72. 72.
    Wekerle H: In vitro induction of immunologial memory against testicular autoantigens. Nature (Lond) 1977;267:357.Google Scholar
  73. 73.
    Wekerle H, Begemann M: Experimental autoimmune orchitis: In vitro induction of an autoimmune disease. J Immunol 1976;116:159.PubMedGoogle Scholar
  74. 74.
    Chaireire J, Michel-Bechet M: Syngeneic sensitization of mouse lymphocytes on monolayers of thyroid epithelial cells. III. Induction of thyroiditis by thyroid-sensitized T lymphoblasts. Eur J Immunol 1982;12:421.Google Scholar
  75. 75.
    Opelz G, Kluchi M, Takasugi M, Terasaki PI: Autologous stimulators of human lymphocyte populations. J Exp Med 1975;142:1327PubMedGoogle Scholar
  76. 76.
    Glimcher LH, Longo DL, Green I, Schwartz RH: Murine syngeneic mixed lymphocyte response. I. Target antigens are self-Ia molecules. J Exp Med 1981;154:1652.PubMedGoogle Scholar
  77. 77.
    Charreire J, Bach J-F: Binding of autologous erythrocytes to immature T cells. Proc Natl Acad Sci USA 1975;721:3201.Google Scholar
  78. 78.
    Carnaud C, Charreire J, Bach J-F: Adult thymectomy promotes the manifestation of autoreactive lymphocytes. Cell Immunol 1977;28:274.PubMedGoogle Scholar
  79. 79.
    Sakaguchi S, Fukuma K, Kuribayashi K, Masuda T: Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance: Deficit of a T cell subset as a possible cause of autolmmune disease. J Exp Med 1985;161:72.PubMedGoogle Scholar
  80. 80.
    Dardenne M, Lepault F, Bendelac A, Bach J-F: Acceleration of the onset of diabetes in NOD mice by thymectomy at weaning. Eur J Immunol 1989;19:889.PubMedGoogle Scholar
  81. 81.
    Harada M, Makino S: Promotion of spontaneous diabetes in nonobese diabetes-prone mice by cyclophosphamide. Diabetologia 1984;27:604.PubMedGoogle Scholar
  82. 82.
    Yasanumi R, Bach J-F: Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur J Immunol 1988;18:481.Google Scholar
  83. 83.
    Like AA, Weringer EJ, Holdash EJ, McGill P, Atkinson D, Rossini A: Adoptive transfer of autoimmune diabetes mellitus in biobreeding/ Worcester (BB/w) inbred and hybrid rats. J Immunol 1985;134:1583.PubMedGoogle Scholar
  84. 84.
    Greiner DL, Moredes JP, Handler ES, Angelillo M, Nakamura N, Rossini AA: Depletion of RT6.1+ T lymphocytes induces diabetes in resistant Biobreeding/Worcester (BB/w) rats. J Exp Med 1987;166:461.PubMedGoogle Scholar
  85. 85.
    Handler ES, Mordes JP, Geisberg M, Nakano K, Rossini AA: Effect of ultraviolet (UVB) and X-irradiation on diabetes prone and resistant BB/w rats (abstract). Diabetes 1985; 34(suppl 1):69.Google Scholar
  86. 86.
    Rossini AA, Mordes JP, Pelletier A, Like AA: Transfusions of whole blood prevent spontaneous diabetes mellitus in the BB/w rat. Science 1983;219:975.PubMedGoogle Scholar
  87. 87.
    Boitard C, Yasunami R, Dardenne M, Bach J-F: T cell mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J Exp Med 1989;169:1669.PubMedGoogle Scholar
  88. 88.
    Ellerman KE, Powers JM, Brostoff SW: A suppressor T lymphocyte cell line for autoimmune encephalomyelitis. Nature (Lond) 1988;331:265.Google Scholar
  89. 89.
    Parish N, Roitt IM, Cooke A: Phenotypic characteristics of cells involved in induced suppression to murine experimental autoimmune thyroiditis. Eur J Immunol 1988;18:1463.PubMedGoogle Scholar
  90. 90.
    Gammon G, Sercaz EE, Benichou G: The dominant self and the cryptic self shaping the autoreactive T cell repertoire. Immunol Today 1991;12:193.PubMedGoogle Scholar
  91. 91.
    Hutchings P, Marshall-Clarke S, Cooke A: Suppression of induced erythrocyte autoantibodies is dependent on Lyt.1 cells. Immunology 1985;56:269.PubMedGoogle Scholar
  92. 92.
    Nishimoto H, Kikutani H, Yamamura K, Kishimoto T: Prevention of autoimmune insulitis by expression of IE molecules in NOD mice. Nature (Lond) 1987;328:432.Google Scholar
  93. 93.
    Sun D, Quin Y, Chluba J, Epplen JT, Wekerle H: Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions. Nature (Lond) 1988;332:843.Google Scholar
  94. 94.
    Gollot E, Mutin M, Touraine YL: Sialadenitis in nonobese diabetic mice: Transfer into syngeneic healthy neonates by splenic T lymphocytes. Clin Immunol Immunopathol 1991;59:462.Google Scholar
  95. 95.
    Hiromatsu Y, Fukazawa H, Wall JR: Cytotoxic mechanisms in autoimmune thyroid disorders and thyroid-associated ephthalmopathy. Endocrinol Metab Clin North Am 1987;16:269.PubMedGoogle Scholar
  96. 96.
    Young LH, Peterson LB, Wicker LS, Persechini PM, Young JD: In vivo expression of perforin by CD8+ lymphocytes in autoimmune disease. Studies on spontaneous and adoptively transferred diabetes in nonobese diabetic mice. J Immunol 1989;143:3994.PubMedGoogle Scholar
  97. 97.
    Held W, MacDonald HR, Weissman IL, Held MW, Mueller C: Genes encoding tumor necrosis factor α and granzyme A are expressed during development of autoimmune diabetes. Proc Natl Acad Sci USA 1990;87:2239.PubMedGoogle Scholar
  98. 98.
    MacKay P, Jacobson J, Rabinovitch A: Spontaneous diabetes mellitus in the bio-breeding/Wcrcester rat. Evidence in vitro for natural killer cell lysis of islet cells. J Clin Invest 1986; 77:916.PubMedGoogle Scholar
  99. 99.
    Boitard C, Chatenoud LM, Debray-Sachs M: In vitro inhibition of pancreatic β cell function by lymphocytes from diabetics with associated autoimmune diseases: A T cell phenomenon. J Immunol 1982;129:2529.PubMedGoogle Scholar
  100. 100.
    Timsit J, Debray-Sachs M, Boitard C, Bach JF: Cell-mediated immunity to pancreatic islet cells in the non-obese diabetic (NOD) mouse: In vitro characterization and time course study. Clin Exp Immunol 1988;73:260.PubMedGoogle Scholar
  101. 101.
    Bendtzen K, Mandrup-Poulsen T, Nerup J, Nielsen JH, Dinarello CA, Svenson M: Cytotoxicity of human interleukin-1 for pancreatic islets of Langerhans. Science 1986;232:1545.PubMedGoogle Scholar
  102. 102.
    Pukel C, Bawuerizo H, Rabinovitch A: Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of interferon gamma, tumor necrosis factor, lymphotoxin and interleukin 1. Diabetes 1988;37:133.PubMedGoogle Scholar
  103. 103.
    Brosnan CF, Selmaj K, Raine CS: Hypothesis: A role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis. J Neuroimmunol 1988;18:87.PubMedGoogle Scholar
  104. 104.
    Hinrichs DJ, Wegmann KW, Dietsch GN: Transfer of experimental allergic encephalomyelitis to bone marrow chimeras. Endothelial cells are not a restricting element. J Exp Med 1987;166:1906.PubMedGoogle Scholar
  105. 105.
    Wang Y, Pontesilli O, Gill RG, La Rosa FG, Lafferty KJ: The role of CD4+ and CD8+ T cells in the destruction of islet grafts by spontaneously diabetic mice. Proc Natl Acad Sci USA 1991;88:527.PubMedGoogle Scholar
  106. 106.
    Hofman FM, Hinton DR, Johnson K, Merrill JE: Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 1989;170:607.PubMedGoogle Scholar
  107. 107.
    Griot C, Burge T, Vandevelde M, Peterhans E: Antibody-induced generation of reactive oxygen radicals by brain macrophages in canine distemper encephalitis: A mechanism for bystander demyelination. ActaNeuropathol (Berlin) 1989;78:396.Google Scholar
  108. 108.
    Huitinga I, Van Rooijen N, de Groot CJ, Uitdehaag BM, Dijkstra CD: Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 1990;172:1025.PubMedGoogle Scholar
  109. 109.
    Frei K, Frederikson S, Fontana A, Link H: Interleukin-6 is elevated in plasma in multiple sclerosis. J Neuroimmunol 1991;31:147.PubMedGoogle Scholar
  110. 110.
    Peter JB, Boctor FN, Tourtelotte WW: Serum and CSF levels of IL-2 S IL2R, TNFα and IL1β in chronic progressive multiple sclerosis: Expected lack of clinical utility. Neurology 1991;41:121.PubMedGoogle Scholar
  111. 111.
    Jacob CO, MacDevitt HO: Tumor necrosis factor α in murine autoimmune ‘lupus’ nephritis. Nature (Lond) 1988;331:356.Google Scholar
  112. 112.
    Satch JJ, Seino H, Abo T, Tanaka S-I, Shintani S, Ohta S, Tamura K, Kumagai K, Toyota T: Recombinant human tumor necrosis factor α suprresses autoimmune diabetes in nonobese diabetic mice. J Clin Invest 1989;84:1345.Google Scholar
  113. 113.
    Weber WEJ, Bcurman WA: Myelin basic protein-specific CD4+ cytolytic T-lymphocyte clones isolated from multiple sclerosis patients. Hum Immunol 1988;22:97.PubMedGoogle Scholar
  114. 114.
    Sun D, Wekerle H: Ia-restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigenpresenting astrocytes. Nature (Lond) 1986;320:70.Google Scholar
  115. 115.
    Spinger TA: Adhesion receptors of the immune system. Nature (Lond) 1990;346:425.Google Scholar
  116. 116.
    Shimizu Y, Shaw S: Lymphocyte interactions with extracellular matrix. FASEB J 1991;5:2292.PubMedGoogle Scholar
  117. 117.
    Hutchings P, Rosen H, O'Reilly L, Simpson E, Gordon S, Cooke A: Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages. Nature (Lond) 1990;348:639.Google Scholar
  118. 118.
    Campbell IL, Cutri A, Wilkinson D, Boyd AW, Harrison L: Intercellular adhesion molecule I is induced on isolated endocrine islet cells by cytokines but not by reovirus infection. Proc Natl Acad Sci USA 1989;86:4282.PubMedGoogle Scholar
  119. 119.
    Alexander EL, Moyer C, Traylos GS, Roths JB, Murphy ED: Two histopathologic types of inflammatory vascular disease in MRL/Lp autoimmune mice. Arthritis Rheum 1985;28:1146.PubMedGoogle Scholar
  120. 120.
    Savino W, Boitard C, Bach J-F, Dardenne M: Studies on the thymus in nonobese diabetic mouse. I. Changes in microenvironmental compartments. Lab Invest 1991;64:105.Google Scholar
  121. 121.
    Garchon HJ, Bedossa P, Eloy L, Bach J-F: Indentification and mapping to chromosome 1 of a susceptibility locus for periinsulitis in NOD (nonobese diabetic) mice. Nature 1991;in press.Google Scholar
  122. 122.
    Bach J-F, Strom TB: The mode of action of immunosuppressive agents; in Research Monographs in Immunology. Amsterdam, Elsevier, 1985, vol 9.Google Scholar
  123. 123.
    Cohen IR: Regulation of autoimmune disease; Physiological and therapeutic. Immunol Rev 1986;94:5.PubMedGoogle Scholar
  124. 124.
    Wraith DC, Smilek DE, Mitchell DJ, Steinman L, McDevitt HO: Antigen recognition in autoimmune encephalomyelitis and the potential for peptide mediated immunotherapy. Cell 1989;59:247PubMedGoogle Scholar
  125. 125.
    Vandenbark AA, Hashim G, Offner H: Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature (Lond) 1989;341:541.Google Scholar
  126. 126.
    Howell MD, Winters ST, Olee T, Powell HC, Carlo DJ, Brostoff SW: Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 1989;246:668.PubMedGoogle Scholar
  127. 127.
    Benjamin RJ, Waldmann H: Induction of tolerance by monoclonal antibody therapy. Nature 1986;320:449.PubMedGoogle Scholar
  128. 128.
    Kelley VE, Gaulton GN, Hattori M, Ikegani H, Eisenbarth G, Strom TB: Anti-interleukin 2 receptor antibody suppresses murine diabetic insulitis and lupus nephritis. J Immunol 1988;140:59.PubMedGoogle Scholar

Copyright information

© Humana Press Inc. 1993

Authors and Affiliations

  • Claude Carnaud
    • 1
  • Jean-François Bach
    • 1
  1. 1.INSERM U 25Hôpital NeckerParisFrance

Personalised recommendations